36865-40-4

Usage

Uses

Used in Pharmaceutical Industry:
1-Bromo-3-ethoxypropane is used as an intermediate in the production of pharmaceuticals for its ability to facilitate the synthesis of various medicinal compounds.
Used in Agrochemical Industry:
Similarly, in the agrochemical industry, 1-Bromo-3-ethoxypropane serves as an intermediate, aiding in the synthesis of different agrochemicals essential for agricultural applications.
Used as a Solvent:
1-Bromo-3-ethoxypropane is utilized as a solvent in various chemical processes due to its ability to dissolve a range of substances, which is crucial for certain reactions to occur.
Used as a Reagent in Chemical Reactions:
1-BROMO-3-ETHOXYPROPANE is also employed as a reagent in a variety of chemical reactions, contributing to the formation of desired products in organic synthesis.
Used in Drug Delivery Research:
1-Bromo-3-ethoxypropane has been studied for its potential use as an agent for delivering drugs to specific targets in the human body, which could enhance the efficacy and precision of drug therapies.

InChI:InChI=1/C5H11BrO/c1-2-7-5-3-4-6/h2-5H2,1H3

Upstream product

• 111-35-3 3-ethoxy-1-propanol 
• 64-17-5 ethanol 
• 109-64-8 1,3-dibromo-propane 
• 627-18-9 1-bromo-3-propanol 
• 74-96-4 ethyl bromide 
• 37480-93-6 trimethylene glycol monosodium salt 
• 337913-25-4 phosphorus pentaoxide 

Downstream Products

• 5848-56-6 hydrocinnamyl ethyl ether 
• 10374-37-5 4-ethoxybutanoic acid 
• 75-19-4 cyclopropane 
• 90949-84-1 2,2-Dimethyl-5-ethoxy-pentannitril 
• 17482-22-3 (3-Ethoxy-propyl)-p-tolyl-sulfid 
• 38460-93-4 Aethyl-<3-aethoxy-propyl>-amin 
• 115643-24-8 2-(3-Ethoxypropyl)-cyclohexanon 
• 187737-37-7 propene 
• 101787-42-2 (4-ethoxybutane-1,1-diyl)dibenzene 
• 102756-09-2 1,7-diethoxy-4,4-diphenyl-heptane 
• 17690-18-5 1-(3-Ethoxy-propane-1-sulfonyl)-4-methyl-benzene 
• 90724-92-8 2,2-Dimethyl-5-ethoxy-pentanol 
• 1261999-56-7 C₃₅H₅₁N₅O₇ 
• 1400705-08-9 (S)-2-({2-[3-(3-hydroxy-phenyl)propylamino]-4,6-dimethyl-pyrimidine-5-carbonyl}amino)-3-[(thiophene-2-carbonyl)amino]propionic acid 3-ethoxy-propyl ester 

Relevant academic research and scientific papers

Optimization of anti-virulence PqsR antagonists regarding aqueous solubility and biological properties resulting in new insights in structure-activity relationships

Increasing antibiotic resistance urgently requires novel therapeutic options to combat bacterial infections. The anti-virulence therapy selectively intervening with pathogenicity without affecting bacterial viability is such a strategy to overcome resistance. We consider the virulence regulator PqsR as an attractive target in the human pathogen Pseudomonas aeruginosa, and recently discovered the first PqsR antagonists, which, however, suffered from poor aqueous solubility. In this work, the antagonists were structurally modified to become more soluble, and their structure-activity as well as structure-property relationships were studied. A novel promising compound with improved solubility and enhanced anti-virulence activity was discovered (IC50: 3.8 μM, pyocyanin). Our findings emphasize the crucial role of substituents at the 3-position and the carbonyl group at the 4-position for ligand-receptor interactions, and illuminate the way for further optimization of PqsR antagonists as anti-virulence agents.

Carbonic anhydrase inhibitors

Compounds of the following formula are disclosed: Compounds of Formula I are the topic of this invention: STR1 Wherein G, J and the two atoms of the thiophene ring to which they are attached form a six-membered ring chosen from STR2 The compounds are usef

Optically active alcohol, process for producing same and liquid crystal compound using same

A liquid crystal compound represented by formula (II) STR1 wherein R denotes a linear alkyl group having 6 to 14 carbon atoms, X denotes a single bond or an oxygen atom, K and L are independently 1 or 2, m is an integer of 5 to 7, n is an integer of 1 to